We also confirmed by bioinformatic analysis [22] and luciferase reporter assay that miR-224 directly targeted RASSF8, a tumor suppressor [23–27], and played an oncogenic role in the progression of cervical cancer. This evidence concerns the gene RASSF8 and cervical carcinoma.